Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-25 @ 3:27 AM
NCT ID:
NCT03443505
Eligibility Criteria:
Inclusion Criteria:
* Age 40-80 years
* Patients hospitalized with a primary diagnosis of an acute exacerbation of COPD
* Body mass index (BMI) ≤ 35 kg/m2
* Cognitively and linguistically able to follow instructions given in English and provide informed consent
* To be discharged to home following the hospitalization
* Patient lives in the catchment area served by the Integrated Respiratory Team at Guy's and St Thomas' NHS Foundation Trust in a home environment deemed safe by the investigators to perform home assessments
Exclusion Criteria:
* Previous home PAP (CPAP or NIV) therapy use within the past year, or post-discharge
* Allergies to latex, metals or local anaesthetic agents
* Wound or inflamed skin at parasternal location (2nd intercostal space)
* History of skin allergies or sensitivity to cosmetics and lotions
* Psychological and social factors that would impair compliance with study protocol and schedule
* Any major non-COPD chronic disease or condition, such as severe heart failure (LVEF\<30%), malignancy (active treatment and palliation), end stage renal failure/dialysis, significant neuromuscular disease (e.g. NMD, MD) determined by review of medical history and / or patient reported medical history that may contribute significantly to risk of readmission, as determined by PI
* Length of stay ≤ 24 hours
* Planned travel away from home within the 30 day post discharge period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT03443505
Study Brief:
Protocol Section:
NCT03443505